what was the first glp-1 agonist π§π΅π² ππ³π³π²π°π πΌπ³ πππ£-π π₯π²π°π²π½ππΌπΏ
Description
Understand the GLP-1 mechanism behind Ozempic and how it helps manage blood sugar, control appetite, and aid in weight loss using semaglutide.
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
It highlights the PIONEER clinical trial programme results, and reviews the efficacy, safety and tolerability.
The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they
Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)
